Haleon to Cut 435 Jobs, Shut U.K. Production Site
By Michael Susin
Haleon said it will shut its toothpaste and mouthwash production site in the U.K. by 2026 and cut 435 jobs.
A spokesperson of the pharmaceutical giant on Tuesday said the Maidenhead manufacturing site is no longer a viable option to manufacture its products. The toothpaste production will be moved to Slovakia, while mouthwash products will be transferred to a third party which is yet to be announced, the spokesperson said.
The proposal, following a review of its global capabilities, is subject to consultation with the affected employees.
Haleon added that it continues to have a substantial presence in the U.K. and that it is investing over 130 million pounds ($163.3 million) in an oral health research and development facility in Weybridge.
Shares at 1223 GMT were up 2% at 338.0 pence.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
April 30, 2024 08:39 ET (12:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Stocks to Buy Instead of Overpriced US Equities
-
Q4 Stock Market Outlook: Where We See Opportunities for Investors
-
Markets Brief: Non-Farm Payrolls in the Spotlight Again
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
The 10 Best Companies to Invest in Now
-
New 4-Star Stocks
-
Morningstar’s Guide to Investing in Stocks
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth